Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants. | Front Endocrinol (Lausanne) | 2023 | 37251668 | PubTator, text mining | PubMed |
| Pan-cancer Analysis Reveals SRC May Link Lipid Metabolism and Macrophages. | Iran J Biotechnol | 2023 | 37228626 | PubTator, text mining | PubMed |
| Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia. | Nat Commun | 2023 | 37217509 | PubTator, text mining | PubMed |
| New small molecules in dermatology: for the autoimmunity, inflammation and beyond. | Inflamm Res | 2023 | 37212867 | PubTator, text mining | PubMed |
| Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery. | ACS Appl Nano Mater | 2023 | 37207132 | PubTator, text mining | PubMed |
| Targeting the Src N-terminal regulatory element in cancer. | Oncotarget | 2023 | 37204272 | PubTator, text mining | PubMed |
| Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapy. | J Thorac Dis | 2023 | 37197539 | PubTator, text mining | PubMed |
| A network causal relationship between type-1 diabetes mellitus, 25-hydroxyvitamin D level and systemic lupus erythematosus: Mendelian randomization study. | PLoS One | 2023 | 37195987 | PubTator, text mining | PubMed |
| Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy. | J Med Chem | 2023 | 37195170 | PubTator, text mining | PubMed |
| Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2. | MedComm (2020) | 2023 | 37193304 | PubTator, text mining | PubMed |
| Covalent Inhibition by a Natural Product-Inspired Latent Electrophile. | J Am Chem Soc | 2023 | 37183434 | PubTator, text mining | PubMed |
| B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma. | Int J Mol Sci | 2023 | 37176092 | PubTator, text mining | PubMed |
| Cross-disorder genetic analysis of immune diseases reveals distinct gene associations that converge on common pathways. | Nat Commun | 2023 | 37173304 | PubTator, text mining | PubMed |
| Discovery of 2,5-diaminopyrimidine derivatives as the first series of selective monomeric degraders of B-lymphoid tyrosine kinase. | Eur J Med Chem | 2023 | 37163946 | PubTator, text mining | PubMed |
| Dasatinib targets c-Src kinase in cardiotoxicity. | Toxicol Rep | 2023 | 37152411 | PubTator, text mining | PubMed |
| Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas. | Cancer Discov | 2023 | 37141112 | PubTator, text mining | PubMed |
| A Systematic Review of the use of Precision Diagnostics in Monogenic Diabetes. | medRxiv | 2023 | 37131594 | PubTator, text mining | PubMed |
| Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities. | Oncogene | 2023 | 37120696 | PubTator, text mining | PubMed |
| MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference. | Sci Rep | 2023 | 37117213 | PubTator, text mining | PubMed |
| Folic Acid-Modified Ibrutinib-Loaded Silk Fibroin Nanoparticles for Cancer Cell Therapy with Over-Expressed Folate Receptor. | Pharmaceutics | 2023 | 37111671 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=12